Right place, right time, right peptide: DO keeps DM focused

被引:55
作者
Denzin, LK
Fallas, JL
Prendes, M
Yi, WS
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, Ithaca, NY 14853 USA
[3] Cornell Univ, Weill Grad Sch Med Sci, Cell Biol & Genet Program, Ithaca, NY 14853 USA
关键词
D O I
10.1111/j.0105-2896.2005.00302.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptide loading of major histocompatibility class II molecules is catalyzed in late endosomal and lysosomal compartments of cells by the catalytic action of human leukocyte antigen (HLA)-DM (H-2M in mice). In B cells, dendritic cells and thymic epithelial cells, the peptide loading of class II molecules is modified by the expression of the non-classical class II molecule, HLA-DO (H-2O in mice). Collectively, studies to date support that DO/H-2O expression inhibits the presentation of antigens acquired by cells via fluid phase endocytosis. However, in B cells, the expression of H-2O promotes the presentation of antigens internalized by the B-cell receptor. In this review, we summarize the literature pertaining to DO assembly, transport, and function, with an emphasis on the function of DO/H-2O.
引用
收藏
页码:279 / 292
页数:14
相关论文
共 123 条
[71]   AN ESSENTIAL ROLE FOR HLA-DM IN ANTIGEN PRESENTATION BY CLASS-II MAJOR HISTOCOMPATIBILITY MOLECULES [J].
MORRIS, P ;
SHAMAN, J ;
ATTAYA, M ;
AMAYA, M ;
GOODMAN, S ;
BERGMAN, C ;
MONACO, JJ ;
MELLINS, E .
NATURE, 1994, 368 (6471) :551-554
[72]   The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation [J].
Mosyak, L ;
Zaller, DM ;
Wiley, DC .
IMMUNITY, 1998, 9 (03) :377-383
[73]   The plasticity of multivesicular bodies and the regulation of antigen presentation [J].
Murk, JL ;
Stoorvogel, W ;
Kleijmeer, MJ ;
Geuze, H .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (04) :303-311
[74]  
MURPHY DB, 1992, J IMMUNOL, V148, P3483
[75]   Class II transactivator is required for maximal expression of HLA-DOB in B cells [J].
Nagarajan, UM ;
Lochamy, J ;
Chen, XJ ;
Beresford, GW ;
Nilsen, R ;
Jensen, PE ;
Boss, JM .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :1780-1786
[76]   The HLA-DOB gene displays limited polymorphism with only one amino acid substitution [J].
Naruse, TK ;
Kawata, H ;
Inoko, H ;
Isshiki, G ;
Yamano, K ;
Hino, M ;
Tatsumi, N .
TISSUE ANTIGENS, 2002, 59 (06) :512-519
[77]   Limited polymorphism in the HLA-DOA gene [J].
Naruse, TK ;
Kawata, H ;
Anzai, T ;
Takashige, N ;
Kagiya, M ;
Nose, Y ;
Nabeya, N ;
Isshiki, G ;
Tatsumi, N ;
Inoko, H .
TISSUE ANTIGENS, 1999, 53 (04) :359-365
[78]   INHIBITION OF ENDOSOMAL PROTEOLYTIC ACTIVITY BY LEUPEPTIN BLOCKS SURFACE EXPRESSION OF MHC CLASS-II MOLECULES AND THEIR CONVERSION TO SDS RESISTANT ALPHA-BETA-HETERODIMERS IN ENDOSOMES [J].
NEEFJES, JJ ;
PLOEGH, HL .
EMBO JOURNAL, 1992, 11 (02) :411-416
[79]   Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides [J].
Pashine, A ;
Busch, R ;
Belmares, MP ;
Munning, JN ;
Doebele, RC ;
Buckingham, M ;
Nolan, GP ;
Mellins, ED .
IMMUNITY, 2003, 19 (02) :183-192
[80]  
Perraudeau M, 2000, EUR J IMMUNOL, V30, P2871, DOI 10.1002/1521-4141(200010)30:10<2871::AID-IMMU2871>3.0.CO